Clinical Trial Update: Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describes the safety and efficacy evaluation of AMT-130 in European adults with early manifest Huntington disease across Phase 1 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• AMT-130

Snippet

Sponsor: UniQure Biopharma B.V. | Conditions: Huntington Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING